Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Sell
29
ANGO Quote, Financials, Valuation and Earnings
Last price:
$9.27
Seasonality move
:
-0.25%
Day range:
$9.02 - $9.44
52-week range:
$5.26 - $13.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.33x
P/B ratio:
2.04x
Volume:
533K
Avg. volume:
571.9K
1-year change:
71.22%
Market cap:
$380.4M
Revenue:
$303.9M
EPS (TTM):
-$5.57
Analysts' Opinion
-
Consensus RatingAngioDynamics has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $15.33, AngioDynamics has an estimated upside of 63.12% from its current price of $9.40.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $15.00 representing 100% downside risk from its current price of $9.40.
Fair Value
-
According to the consensus of 2 analysts, AngioDynamics has 63.12% upside to fair value with a price target of $15.33 per share.
ANGO vs. S&P 500
-
Over the past 5 trading days, AngioDynamics has overperformed the S&P 500 by 3.49% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AngioDynamics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AngioDynamics revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter AngioDynamics reported revenues of $72.8M.
Earnings Growth
-
AngioDynamics has grown year-over-year earnings for 1 quarter straight. In the most recent quarter AngioDynamics reported earnings per share of -$0.26.
Enterprise value:
331.2M
EV / Invested capital:
--
Price / LTM sales:
1.33x
EV / EBIT:
--
EV / Revenue:
1.16x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-11.18x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
55.72x
Gross Profit (TTM):
$151M
Return On Assets:
-65.05%
Net Income Margin (TTM):
-78.44%
Return On Equity:
-92.95%
Return On Invested Capital:
-91.85%
Operating Margin:
-6.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Income Statement | ||||||
| Revenue | $327.9M | $329.5M | $286.5M | $79.1M | $72.8M | |
| Gross Profit | $172.4M | $167.2M | $151M | $40.3M | $39.9M | |
| Operating Income | -$17.9M | -$24.2M | -$31.2M | -$6.7M | -$5.1M | |
| EBITDA | $12.6M | $4.6M | -$3.2M | -$26K | $1.8M | |
| Diluted EPS | -$0.83 | -$0.35 | -$5.57 | -$0.72 | -$0.26 | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $149.7M | $132.2M | $158.8M | $185.5M | $175.4M | |
| Total Assets | $588.5M | $554.1M | $558.2M | $499.6M | $291.6M | |
| Current Liabilities | $45.8M | $54.5M | $73.6M | $78M | $88.6M | |
| Total Liabilities | $134.2M | $121.7M | $150.2M | $98.4M | $104.8M | |
| Total Equity | $454.3M | $432.4M | $408M | $401.2M | $186.8M | |
| Total Debt | $40M | $25M | $49.8M | -- | $5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2023-11-30 | 2024-11-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$17.5M | -$3.3M | -$23.3M | $5.3M | $2.5M | |
| Cash From Investing | -$12.4M | $93M | $22.7M | -$1.8M | -$2M | |
| Cash From Financing | $25.8M | -$59M | -$5.9M | -$352K | -$1.1M | |
| Free Cash Flow | -$21.7M | -$6.9M | -$29.6M | $4.7M | $1.7M | |
ANGO
Sector
Market Cap
$380.4M
$38.4M
Price % of 52-Week High
69.63%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.78%
1-Year Price Total Return
71.22%
-39.05%
Beta (5-Year)
0.564
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$9.30
200-day SMA
Buy
Level
$7.92
Bollinger Bands (100)
Buy
Level
7 - 10.98
Chaikin Money Flow
Sell
Level
-3.2M
20-day SMA
Sell
Level
$9.93
Relative Strength Index (RSI14)
Sell
Level
43.38
ADX Line
Sell
Level
25.89
Williams %R
Neutral
Level
-54.9801
50-day SMA
Sell
Level
$10.63
MACD (12, 26)
Sell
Level
-0.44
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-8.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6148)
Buy
CA Score
(Annual)
Level (0.3136)
Buy
Beneish M-Score
(Annual)
Level (-3.086)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.1567)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Stock Forecast FAQ
In the current month, ANGO has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ANGO average analyst price target in the past 3 months is $15.33.
-
Where Will AngioDynamics Stock Be In 1 Year?
According to analysts, the consensus estimate is that AngioDynamics share price will rise to $15.33 per share over the next 12 months.
-
What Do Analysts Say About AngioDynamics?
Analysts are divided on their view about AngioDynamics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AngioDynamics is a Sell and believe this share price will drop from its current level to $15.00.
-
What Is AngioDynamics's Price Target?
The price target for AngioDynamics over the next 1-year time period is forecast to be $15.33 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ANGO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AngioDynamics is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ANGO?
You can purchase shares of AngioDynamics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AngioDynamics shares.
-
What Is The AngioDynamics Share Price Today?
AngioDynamics was last trading at $9.27 per share. This represents the most recent stock quote for AngioDynamics. Yesterday, AngioDynamics closed at $9.40 per share.
-
How To Buy AngioDynamics Stock Online?
In order to purchase AngioDynamics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Is Walmart the Largest Retailer in the World?
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
50
TREE alert for Mar 13
LendingTree [TREE] is up 0.94% over the past day.
Buy
57
INOD alert for Mar 13
Innodata [INOD] is down 7.34% over the past day.
Sell
40
VIST alert for Mar 13
Vista Energy SAB de CV [VIST] is down 0.3% over the past day.
